Skip to main content
Erschienen in: Pediatric Radiology 8/2016

04.04.2016 | Original Article

Imaging of primary pediatric lymphoma of bone

verfasst von: Kathryn S. Milks, Thomas W. McLean, Evelyn Y. Anthony

Erschienen in: Pediatric Radiology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary pediatric bone lymphoma is a rare form of non-Hodgkin lymphoma. Unlike nodal forms of lymphoma, imaging abnormalities in lymphoma of bone do not resolve rapidly in conjunction with treatment and radiologic findings can remain abnormal for years, making it difficult to evaluate treatment response.

Objective

To evaluate the utility of imaging in assessment of patients with primary pediatric bone lymphoma.

Materials and methods

At our institution between 2004 and 2013, six cases of pathology-proven primary pediatric bone lymphoma were diagnosed. Retrospective chart review was performed to assess imaging utilization. Our data were qualitatively compared with existing literature to construct an algorithm for imaging patients with primary lymphoma of bone.

Results

Imaging evaluation of patients with primary pediatric bone lymphoma was highly variable at our institution. Conventional imaging was routinely used to evaluate response to treatment, despite lack of appreciable osseous change. Imaging in the absence of symptoms did not alter clinical management. Only positron emission tomography CT (PET/CT) proved capable of demonstrating imaging changes from the pretreatment to the post-treatment scans that were consistent with the clinical response to treatment.

Conclusion

Surveillance imaging is likely unnecessary in patients with a known diagnosis of pediatric lymphoma of bone. Pretreatment and post-treatment PET/CT is likely sufficient to assess response. There is little data to support the use of interim and surveillance PET/CT.
Literatur
1.
Zurück zum Zitat Lones MA, Perkins SL, Sposto R et al (2002) Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol 20:2293–2301CrossRefPubMed Lones MA, Perkins SL, Sposto R et al (2002) Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol 20:2293–2301CrossRefPubMed
2.
Zurück zum Zitat Zhao XF, Young KH, Frank D et al (2007) Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases. Am J Clin Pathol 127:47–54CrossRefPubMed Zhao XF, Young KH, Frank D et al (2007) Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases. Am J Clin Pathol 127:47–54CrossRefPubMed
3.
Zurück zum Zitat Ramadan KM, Shenkier T, Sehn LH et al (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 18:129–135CrossRefPubMed Ramadan KM, Shenkier T, Sehn LH et al (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 18:129–135CrossRefPubMed
4.
Zurück zum Zitat Suryanarayan K, Shuster JJ, Donaldson SS et al (1999) Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol 17:456–459PubMed Suryanarayan K, Shuster JJ, Donaldson SS et al (1999) Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol 17:456–459PubMed
5.
Zurück zum Zitat Borowitz MJ, Wood BL, Devidas M et al (2015) Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood 126:964–971CrossRefPubMed Borowitz MJ, Wood BL, Devidas M et al (2015) Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood 126:964–971CrossRefPubMed
6.
Zurück zum Zitat Furman WL, Fitch S, Hustu HO et al (1989) Primary lymphoma of bone in children. J Clin Oncol 7:1275–1280PubMed Furman WL, Fitch S, Hustu HO et al (1989) Primary lymphoma of bone in children. J Clin Oncol 7:1275–1280PubMed
7.
Zurück zum Zitat Glotzbecker MP, Kersun LS, Choi JK et al (2006) Primary non-Hodgkin's lymphoma of bone in children. J Bone Joint Surg Am 88:583–594CrossRefPubMed Glotzbecker MP, Kersun LS, Choi JK et al (2006) Primary non-Hodgkin's lymphoma of bone in children. J Bone Joint Surg Am 88:583–594CrossRefPubMed
8.
Zurück zum Zitat Borst AJ, States LJ, Reilly AF, Rheingold SR et al (2013) Determining response and recurrence in pediatric B-cell lymphomas of the bone. Pediatr Blood Cancer 60:1281–1286 Borst AJ, States LJ, Reilly AF, Rheingold SR et al (2013) Determining response and recurrence in pediatric B-cell lymphomas of the bone. Pediatr Blood Cancer 60:1281–1286
9.
Zurück zum Zitat Okada M, Sato N, Ishii K et al (2010) FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma. Radiographics 30:939–957CrossRefPubMed Okada M, Sato N, Ishii K et al (2010) FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma. Radiographics 30:939–957CrossRefPubMed
10.
Zurück zum Zitat Ferrari C, Minoia C, Asabella AN et al (2014) Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma. Hell J Nucl Med 1:40–49 Ferrari C, Minoia C, Asabella AN et al (2014) Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma. Hell J Nucl Med 1:40–49
11.
Zurück zum Zitat Moog F, Bangerter M, Diederichs CG et al (1998) Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 206:475–481CrossRefPubMed Moog F, Bangerter M, Diederichs CG et al (1998) Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 206:475–481CrossRefPubMed
12.
Zurück zum Zitat Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068CrossRefPubMed Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068CrossRefPubMed
13.
Zurück zum Zitat Elstrom RL, Leonard JP, Coleman M et al (2008) Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 19:1770–1773CrossRefPubMedPubMedCentral Elstrom RL, Leonard JP, Coleman M et al (2008) Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 19:1770–1773CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413PubMed Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413PubMed
15.
Zurück zum Zitat Quarles van Ufford H, Hoekstra O, de Haas M et al (2010) On the added value of baseline FDG-PET in malignant lymphoma. Mol Imaging Biol 12:225–232CrossRefPubMed Quarles van Ufford H, Hoekstra O, de Haas M et al (2010) On the added value of baseline FDG-PET in malignant lymphoma. Mol Imaging Biol 12:225–232CrossRefPubMed
16.
Zurück zum Zitat Herrmann K, Queiroz M, Huellner MW et al (2015) Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT. BMC Cancer 15:1002CrossRefPubMedPubMedCentral Herrmann K, Queiroz M, Huellner MW et al (2015) Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT. BMC Cancer 15:1002CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Pfluger T, Melzer H, Mueller W et al (2012) Diagnostic value of combined 18F-FDG PET/MRI for staging and restaging in paediatric oncology Eur J Nucl Med Mol Imaging 39:1745–1755 Pfluger T, Melzer H, Mueller W et al (2012) Diagnostic value of combined 18F-FDG PET/MRI for staging and restaging in paediatric oncology Eur J Nucl Med Mol Imaging 39:1745–1755
19.
Zurück zum Zitat Krishnasetty V, Bonab AA, Fischman AJ et al (2008) Comparison of standard-dose vs low-dose attenuation correction CT on image quality and positron emission tomographic attenuation correction. J Am Coll Radiol 5:579–584 Krishnasetty V, Bonab AA, Fischman AJ et al (2008) Comparison of standard-dose vs low-dose attenuation correction CT on image quality and positron emission tomographic attenuation correction. J Am Coll Radiol 5:579–584
20.
Zurück zum Zitat Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29:1844–1854 Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29:1844–1854
21.
Zurück zum Zitat Abramson SJ, Price AP (2008) Imaging of pediatric lymphomas. Radiol Clin North Am 46:313–338, ixCrossRefPubMed Abramson SJ, Price AP (2008) Imaging of pediatric lymphomas. Radiol Clin North Am 46:313–338, ixCrossRefPubMed
22.
Zurück zum Zitat Friedman DL, Chen L, Wolden S et al (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. J Clin Oncol 32:3651–3658CrossRefPubMedPubMedCentral Friedman DL, Chen L, Wolden S et al (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. J Clin Oncol 32:3651–3658CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Zhu D, Xu XL, Fang C et al (2015) Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis. Int J Clin Exp Med 8:15340–15350PubMedPubMedCentral Zhu D, Xu XL, Fang C et al (2015) Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis. Int J Clin Exp Med 8:15340–15350PubMedPubMedCentral
24.
Zurück zum Zitat Kaste SC, Shulkin BL (2006) 18F-Fluorodeoxyglucose PET/CT in Childhood Lymphoma. PET Clin 1:265–273CrossRefPubMed Kaste SC, Shulkin BL (2006) 18F-Fluorodeoxyglucose PET/CT in Childhood Lymphoma. PET Clin 1:265–273CrossRefPubMed
25.
Zurück zum Zitat Jhanwar YS, Straus DJ (2006) The role of PET in lymphoma. J Nucl Med 47:1326–1334PubMed Jhanwar YS, Straus DJ (2006) The role of PET in lymphoma. J Nucl Med 47:1326–1334PubMed
26.
Zurück zum Zitat Zinzani PL, Stefoni V, Tani M et al (2009) Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 27:1781–1787CrossRefPubMed Zinzani PL, Stefoni V, Tani M et al (2009) Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 27:1781–1787CrossRefPubMed
27.
Zurück zum Zitat Jerusalem G, Beguin Y, Fassotte MF et al (2003) Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol 14:123–130CrossRefPubMed Jerusalem G, Beguin Y, Fassotte MF et al (2003) Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol 14:123–130CrossRefPubMed
28.
Zurück zum Zitat Cashen AF, Dehdashti F, Luo J et al (2011) 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation. J Nucl Med 52:386–392CrossRefPubMedPubMedCentral Cashen AF, Dehdashti F, Luo J et al (2011) 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation. J Nucl Med 52:386–392CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Truong Q, Shah N, Knestrick M et al (2014) Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission. Clin Lymphoma Myeloma Leuk 14:50–55CrossRefPubMed Truong Q, Shah N, Knestrick M et al (2014) Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission. Clin Lymphoma Myeloma Leuk 14:50–55CrossRefPubMed
30.
Zurück zum Zitat Thompson CA, Ghesquieres H, Maurer MJ et al (2014) Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol 32:3506–3512CrossRefPubMedPubMedCentral Thompson CA, Ghesquieres H, Maurer MJ et al (2014) Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol 32:3506–3512CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Mengiardi B, Honegger H, Hodler J et al (2005) Primary lymphoma of bone: MRI and CT characteristics during and after successful treatment. AJR Am J Roentgenol 184:185–192CrossRefPubMed Mengiardi B, Honegger H, Hodler J et al (2005) Primary lymphoma of bone: MRI and CT characteristics during and after successful treatment. AJR Am J Roentgenol 184:185–192CrossRefPubMed
32.
Zurück zum Zitat Eissa HM, Allen CE, Kamdar K et al (2014) Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required? Pediatr Hematol Oncol 31:253–257CrossRefPubMed Eissa HM, Allen CE, Kamdar K et al (2014) Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required? Pediatr Hematol Oncol 31:253–257CrossRefPubMed
Metadaten
Titel
Imaging of primary pediatric lymphoma of bone
verfasst von
Kathryn S. Milks
Thomas W. McLean
Evelyn Y. Anthony
Publikationsdatum
04.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 8/2016
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3597-8

Weitere Artikel der Ausgabe 8/2016

Pediatric Radiology 8/2016 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.